Published in Cold Spring Harb Perspect Biol on December 23, 2009
NF-κB in immunobiology. Cell Res (2011) 2.61
The noncanonical NF-κB pathway. Immunol Rev (2012) 2.57
MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J (2013) 2.01
Dynamics of B cells in germinal centres. Nat Rev Immunol (2015) 1.61
B-1 B cell development in the fetus and adult. Immunity (2012) 1.47
NF-κB: roles and regulation in different CD4(+) T-cell subsets. Immunol Rev (2013) 1.45
Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain. Biochemistry (2010) 1.16
Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy (2012) 1.16
The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol Cell Biol (2011) 1.14
Germinal center B cell maintenance and differentiation are controlled by distinct NF-κB transcription factor subunits. J Exp Med (2014) 1.07
Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo. PLoS One (2013) 1.02
The c-Rel Transcription Factor in Development and Disease. Genes Cancer (2011) 1.01
B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1.01
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency. Am J Hum Genet (2015) 1.00
Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc Natl Acad Sci U S A (2011) 0.99
Control of vertebrate development by MYC. Cold Spring Harb Perspect Med (2013) 0.94
Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival. Blood (2012) 0.92
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. Cell (2017) 0.92
Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells. J Immunol (2013) 0.91
Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production. J Exp Med (2012) 0.91
Chronic activation of the kinase IKKβ impairs T cell function and survival. J Immunol (2012) 0.91
The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia. Leukemia (2013) 0.89
Protein kinase D2 has a restricted but critical role in T-cell antigen receptor signalling in mature T-cells. Biochem J (2012) 0.88
Formation of B-1 B cells from neonatal B-1 transitional cells exhibits NF-κB redundancy. J Immunol (2011) 0.87
Cell-intrinsic NF-κB activation is critical for the development of natural regulatory T cells in mice. PLoS One (2011) 0.87
IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen. J Exp Med (2014) 0.87
A multi-scale approach reveals that NF-κB cRel enforces a B-cell decision to divide. Mol Syst Biol (2015) 0.85
A key role for NF-κB transcription factor c-Rel in T-lymphocyte-differentiation and effector functions. Clin Dev Immunol (2012) 0.85
Olive (Olea europaea) leaf extract induces apoptosis and monocyte/macrophage differentiation in human chronic myelogenous leukemia K562 cells: insight into the underlying mechanism. Oxid Med Cell Longev (2014) 0.85
Role of diacylglycerol kinases in T cell development and function. Crit Rev Immunol (2013) 0.85
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res Ther (2015) 0.84
Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells. J Immunol (2016) 0.84
c-Rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells. PLoS One (2011) 0.84
Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment. Cytokine Growth Factor Rev (2015) 0.83
Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes. Clin Exp Immunol (2014) 0.82
Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats. Am J Respir Cell Mol Biol (2014) 0.82
The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties. EMBO J (2011) 0.82
NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells. J Exp Med (2016) 0.81
Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation. J Virol (2012) 0.81
Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways. Immun Inflamm Dis (2013) 0.80
B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel. Blood (2016) 0.79
Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation. Mol Cell Biol (2013) 0.79
Enhancer repertoires are reshaped independently of early priming and heterochromatin dynamics during B cell differentiation. Nat Commun (2015) 0.79
CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia. Blood (2015) 0.78
Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-κB. PLoS One (2014) 0.78
Systematic identification of protein combinations mediating chromatin looping. Nat Commun (2016) 0.77
Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells. Proc Natl Acad Sci U S A (2016) 0.77
Signaling in lymphocyte activation. Cold Spring Harb Perspect Biol (2015) 0.77
NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas. PLoS One (2014) 0.77
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. Sci Rep (2016) 0.76
Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development. Proc Natl Acad Sci U S A (2016) 0.76
Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis. Curr Opin Hematol (2015) 0.76
Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines. Molecules (2015) 0.76
Endogenous n-3 Polyunsaturated Fatty Acids Attenuate T Cell-Mediated Hepatitis via Autophagy Activation. Front Immunol (2016) 0.75
c-Rel: shaping CD4 regulatory T cell development in unexpected ways. Transcription (2012) 0.75
Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions. Cells (2016) 0.75
Differential requirements for the canonical NF-κB transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunol Cell Biol (2016) 0.75
Ribosomal Protein S3 Gene Silencing Protects Against Experimental Allergic Asthma. Br J Pharmacol (2017) 0.75
Negative role of TAK1 in marginal zone B-cell development incidental to NF-κB noncanonical pathway activation. Immunol Cell Biol (2016) 0.75
The Lysine Methyltransferase G9a in Immune Cell Differentiation and Function. Front Immunol (2017) 0.75
Quantifying deleterious effects of regulatory variants. Nucleic Acids Res (2016) 0.75
Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia. BMC Genomics (2017) 0.75
Disruption of Tumor Necrosis Factor Receptor-Associated Factor 5 Exacerbates Murine Experimental Colitis via Regulating T Helper Cell-Mediated Inflammation. Mediators Inflamm (2016) 0.75
Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens. Front Immunol (2016) 0.75
A20 Curtails Primary but Augments Secondary CD8(+) T Cell Responses in Intracellular Bacterial Infection. Sci Rep (2016) 0.75
The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region. Toxicol Sci (2015) 0.75
Functions of protein phosphatase-6 in NF-κB signaling and in lymphocytes. Biochem Soc Trans (2017) 0.75
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. Oncogene (2017) 0.75
B cells in type 1 diabetes mellitus and diabetic kidney disease. Nat Rev Nephrol (2017) 0.75
Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist. Sci Rep (2017) 0.75
Synergistic cooperation and crosstalk between MYD88(L265P) and mutations that dysregulate CD79B and surface IgM. J Exp Med (2017) 0.75
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76
CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol (2001) 9.19
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell (1995) 7.55
Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med (2001) 6.66
IRF4 addiction in multiple myeloma. Nature (2008) 6.27
Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol (2005) 6.13
New regulators of NF-kappaB in inflammation. Nat Rev Immunol (2008) 5.79
Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev (1997) 5.65
NF-kappaB and the immune response. Oncogene (2006) 5.62
Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev (1995) 5.51
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature (2000) 5.48
CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol (2008) 5.35
Antigen-specific memory B cell development. Annu Rev Immunol (2005) 5.28
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol (2002) 5.09
Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell (1995) 4.70
The many roles of FAS receptor signaling in the immune system. Immunity (2009) 4.67
Aire. Annu Rev Immunol (2009) 4.43
The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37
A central role for central tolerance. Annu Rev Immunol (2006) 4.31
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science (1997) 4.23
Cracking the BAFF code. Nat Rev Immunol (2009) 3.95
Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity (2006) 3.74
A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol (2001) 3.74
Signatures of the immune response. Immunity (2001) 3.66
NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell (2000) 3.60
A fourth IkappaB protein within the NF-kappaB signaling module. Cell (2007) 3.34
E2f3 is critical for normal cellular proliferation. Genes Dev (2000) 3.26
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology (2005) 3.18
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol (2004) 3.17
Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol (2006) 3.15
The who, how and where of antigen presentation to B cells. Nat Rev Immunol (2009) 3.12
CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol (2009) 3.00
Mechanism and control of class-switch recombination. Trends Immunol (2002) 2.95
Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol (2007) 2.94
NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci U S A (1999) 2.83
Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev (1999) 2.82
The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity (2008) 2.81
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80
Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78
NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci U S A (1990) 2.75
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70
NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med (1997) 2.66
The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol (2006) 2.65
The protean nature of cells in the B lymphocyte lineage. Immunity (2007) 2.64
Peripheral B cell subsets. Curr Opin Immunol (2008) 2.60
The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity (2008) 2.57
TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol (2004) 2.51
T(H)-17 differentiation: of mice and men. Nat Immunol (2007) 2.40
Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol (2006) 2.38
Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene (2006) 2.33
Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity (2002) 2.31
Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol (2005) 2.28
Epigenetic ontogeny of the Igk locus during B cell development. Nat Immunol (2004) 2.25
Mature T cells depend on signaling through the IKK complex. Immunity (2003) 2.21
Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol (2008) 2.20
Essential role of TAK1 in thymocyte development and activation. Proc Natl Acad Sci U S A (2006) 2.19
RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J (2003) 2.17
Development of secondary lymphoid organs. Annu Rev Immunol (2008) 2.10
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A (2004) 2.09
Genetic control of cell size. Curr Opin Genet Dev (2000) 2.08
NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol Cell (2003) 2.08
Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity. Immunity (2008) 2.07
Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol (2009) 2.07
TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature (1999) 2.01
B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med (1998) 2.00
Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol (2008) 1.96
Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol (2001) 1.95
IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med (2002) 1.93
Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J Exp Med (2003) 1.93
c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J Exp Med (2001) 1.92
Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med (2000) 1.92
NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J Immunol (2004) 1.92
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity (2000) 1.91
Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway. Immunol Rev (2003) 1.88
DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature (2008) 1.88
Thymic development and peripheral homeostasis of regulatory T cells. Curr Opin Immunol (2007) 1.88
Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem (2003) 1.87
The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med (2009) 1.87
Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med (1997) 1.85
A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity (2005) 1.81
The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J (2000) 1.79
Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development. J Exp Med (2003) 1.77
IkappaB kinase alpha is essential for mature B cell development and function. J Exp Med (2001) 1.76
Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity (2002) 1.74
IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity (2001) 1.73
How the Dorsal gradient works: insights from postgenome technologies. Proc Natl Acad Sci U S A (2008) 1.70
TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int Immunol (2006) 1.70
Development and selection of gammadelta T cells. Immunol Rev (2007) 1.70
Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol (2000) 1.70
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther (2008) 1.68
Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle (2007) 1.68
c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol (2003) 1.64
Aire controls the differentiation program of thymic epithelial cells in the medulla for the establishment of self-tolerance. J Exp Med (2008) 1.63
The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ (1994) 1.62
Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood (2006) 1.61
The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc Natl Acad Sci U S A (2002) 1.59
Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J Immunol (2007) 1.59
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol (2002) 5.09
Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell (2009) 3.80
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell (2006) 2.02
BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem (2004) 1.92
Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem (2003) 1.87
The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol (2009) 1.76
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther (2008) 1.68
Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem (2002) 1.55
GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Mol Cell (2004) 1.42
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity (2012) 1.30
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J Bone Miner Res (2002) 1.30
Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J Biol Chem (2007) 1.30
NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest (2006) 1.29
Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation. J Immunol (2005) 1.24
IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms. J Biol Chem (2011) 1.16
A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance. Immunity (2007) 1.09
CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy. J Mol Cell Cardiol (2012) 1.06
Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65. J Cell Sci (2005) 1.06
Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. J Bone Miner Res (2003) 0.94
CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction. Cell Signal (2012) 0.93
Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling. Free Radic Biol Med (2013) 0.92
Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun (2013) 0.91
Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations. Hum Mol Genet (2011) 0.91
The IκB family member Bcl-3 stabilizes c-Myc in colorectal cancer. J Mol Cell Biol (2013) 0.90
The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody. Arthritis Rheum (2010) 0.89
TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiation. Cell Signal (2013) 0.89
CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis. J Immunol (2012) 0.87
Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. Cell Signal (2013) 0.87
NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells. J Immunol (2007) 0.86
The IκB family member Bcl-3 coordinates the pulmonary defense against Klebsiella pneumoniae infection. J Immunol (2011) 0.85
The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development. J Immunol (2013) 0.83
TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development. Proc Natl Acad Sci U S A (2013) 0.82
Improved antibacterial host defense and altered peripheral granulocyte homeostasis in mice lacking the adhesion class G protein receptor CD97. Infect Immun (2006) 0.81
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets. Curr Med Chem (2003) 0.80
Cell-autonomous role for NF-kappa B in immature bone marrow B cells. J Immunol (2009) 0.79
Established thymic epithelial progenitor/stem cell-like cell lines differentiate into mature thymic epithelial cells and support T cell development. PLoS One (2013) 0.75
Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a. J Interferon Cytokine Res (2013) 0.75
TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. Am J Physiol Heart Circ Physiol (2017) 0.75